Entrada Therapeutics shares owned by Advantage Alpha Capital Partners
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Advantage Alpha Capital Partners
from 13F filings
Historical chart of Advantage Alpha Capital Partners investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Advantage Alpha Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Advantage Alpha Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $285 | 20 | 14.25 |
| 2024-03-31 | $1.3M | 91k | 14.17 |
More positions owned by Advantage Alpha Capital Partners
View all positions for Advantage Alpha Capital Partners